• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织调节异常对2型糖尿病的影响。

The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus.

作者信息

Rausch Jamie, Horne Kaitlyn E, Marquez Luis

机构信息

School of Nursing, Indiana University, Fort Wayne Campus, Fort Wayne, IN 46805, USA.

Independent Researcher, Fort Wayne, IN 46805, USA.

出版信息

Biomedicines. 2025 Jul 19;13(7):1770. doi: 10.3390/biomedicines13071770.

DOI:10.3390/biomedicines13071770
PMID:40722840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12292160/
Abstract

Internationally, the prevalence of type 2 diabetes mellitus (T2DM) and obesity rates are increasing significantly. As these epidemics continue to spread, the continuation of further research is paramount given that chronic diseases, such as T2DM, cause strain on both economies and healthcare systems. Recently, adipose tissue has been identified as an endocrine organ that produces many hormones that influence many bodily processes. Adipose tissue dysregulation (ATD)-when adipokines (adipose tissue hormones) are produced in abnormal amounts-plays an important role in T2DM development, progression, and prognosis. This narrative review focuses on mechanisms linking ATD with T2DM through adipokine actions (specifically, leptin and adiponectin) on insulin resistance and glucose metabolism. Here we show that the adipokines leptin and adiponectin are valuable in monitoring, diagnosing, and treating diseases. Further, their ratio (the leptin-to-adiponectin ratio, or LAR) may be more valuable than either adipokine individually. The LAR may give researchers the ability to utilize a primary prevention approach by utilizing LAR as a biomarker influencing early prognosis and treatment. Targeting ATD through diet, weight loss, physical activity, etc., may improve prevention and management outcomes for patients living with or at risk of T2DM.

摘要

在国际上,2型糖尿病(T2DM)的患病率和肥胖率正在显著上升。随着这些流行病的持续蔓延,鉴于诸如T2DM之类的慢性病给经济和医疗系统都带来压力,继续开展进一步研究至关重要。最近,脂肪组织已被确认为一种内分泌器官,它能产生许多影响身体诸多过程的激素。脂肪组织功能失调(ATD)——即脂肪因子(脂肪组织激素)产生量异常时——在T2DM的发生、发展和预后中起重要作用。这篇叙述性综述聚焦于通过脂肪因子(具体而言,瘦素和脂联素)对胰岛素抵抗和葡萄糖代谢的作用将ATD与T2DM联系起来的机制。在此我们表明,脂肪因子瘦素和脂联素在疾病的监测、诊断和治疗中具有重要价值。此外,它们的比值(瘦素与脂联素比值,即LAR)可能比单独的任何一种脂肪因子更有价值。LAR可能使研究人员有能力通过将LAR用作影响早期预后和治疗的生物标志物来采用一级预防方法。通过饮食、减重、体育活动等针对ATD进行干预,可能会改善T2DM患者或有T2DM风险人群的预防和管理效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/391b98954796/biomedicines-13-01770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/381f54d158ee/biomedicines-13-01770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/5ad3e5ce475b/biomedicines-13-01770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/391b98954796/biomedicines-13-01770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/381f54d158ee/biomedicines-13-01770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/5ad3e5ce475b/biomedicines-13-01770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/12292160/391b98954796/biomedicines-13-01770-g003.jpg

相似文献

1
The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus.脂肪组织调节异常对2型糖尿病的影响。
Biomedicines. 2025 Jul 19;13(7):1770. doi: 10.3390/biomedicines13071770.
2
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
3
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Short-Term Memory Impairment短期记忆障碍
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Neurotransmitter Alterations in Prediabetes and Type 2 Diabetes Mellitus: A Narrative Review.前驱糖尿病和2型糖尿病中的神经递质改变:一项叙述性综述
Int J Mol Sci. 2025 Aug 14;26(16):7847. doi: 10.3390/ijms26167847.

本文引用的文献

1
Is Adipose Tissue Inflammation the Culprit of Obesity-Associated Comorbidities?脂肪组织炎症是肥胖相关合并症的罪魁祸首吗?
Obes Rev. 2025 Jun 18:e13956. doi: 10.1111/obr.13956.
2
Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes.显著体重减轻对肥胖和2型糖尿病患者脂肪组织生物学的影响。
Diabetes Care. 2025 Aug 1;48(8):1342-1351. doi: 10.2337/dc24-2739.
3
Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions.
2型糖尿病中胰岛素抵抗与免疫失调之间的相互作用:对治疗干预的启示
Immunotargets Ther. 2025 Apr 3;14:359-382. doi: 10.2147/ITT.S499605. eCollection 2025.
4
Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases.脂肪组织与其他器官相互作用中的脂肪因子:对心血管代谢疾病的影响
Biomedicines. 2024 Sep 19;12(9):2129. doi: 10.3390/biomedicines12092129.
5
The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.肥胖症中瘦素抵抗的机制与治疗展望。
Adv Exp Med Biol. 2024;1460:463-487. doi: 10.1007/978-3-031-63657-8_16.
6
Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.肥胖中的脂联素抵抗:脂联素-瘦素/胰岛素相互作用。
Adv Exp Med Biol. 2024;1460:431-462. doi: 10.1007/978-3-031-63657-8_15.
7
Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.肥胖症中的脂肪组织缺氧:缺氧假说的临床再评价。
Adv Exp Med Biol. 2024;1460:329-356. doi: 10.1007/978-3-031-63657-8_11.
8
History and future of leptin: Discovery, regulation and signaling.瘦素的历史和未来:发现、调节和信号转导。
Metabolism. 2024 Dec;161:156026. doi: 10.1016/j.metabol.2024.156026. Epub 2024 Sep 7.
9
Mechanism of Action and Risk Prediction of Adiponectin in Cardiovascular Diseases.脂联素在心血管疾病中的作用机制与风险预测。
Front Biosci (Landmark Ed). 2024 Aug 19;29(8):286. doi: 10.31083/j.fbl2908286.
10
Adiposity modifies the association between heart failure risk and glucose metabolic disorder in older individuals: a community-based prospective cohort study.肥胖会改变心力衰竭风险与老年人葡萄糖代谢紊乱之间的关联:一项基于社区的前瞻性队列研究。
Cardiovasc Diabetol. 2024 Aug 27;23(1):318. doi: 10.1186/s12933-024-02418-5.